The route of immunization with adenoviral vaccine influences the recruitment of cytotoxic T lymphocytes in the lung that provide potent protection from influenza A virus

Antiviral Research

Volumn 91, Issue 3, 2011, Pages 252-258

  Suda, Tatsuya ^a,b   Kawano, Masaaki ^a   Nogi, Yasuhisa ^a   Ohno, Naohito ^b   Akatsuka, Toshitaka ^a   Matsui, Masanori ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

Adenoviral vaccine; Cytotoxic T lymphocyte; Hock immunization; Immunization route; Influenza A virus

Indexed keywords

GAMMA INTERFERON; VIRUS VACCINE;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; IMMUNIZATION; INFLUENZA A; INFLUENZA VIRUS A; LUNG; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY VIRUS; SPLEEN; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELL MOVEMENT; DRUG ADMINISTRATION ROUTES; FEMALE; FLOW CYTOMETRY; GENETIC VECTORS; HUMANS; INFLUENZA A VIRUS; INFLUENZA VACCINES; INJECTIONS, SUBCUTANEOUS; INTERFERON-GAMMA; LUNG; MICE; MICE, INBRED C57BL; ORTHOMYXOVIRIDAE INFECTIONS; SPLEEN; VACCINATION; VACCINES, SYNTHETIC; VIRAL MATRIX PROTEINS;

ADENOVIRIDAE; INFLUENZA A VIRUS; MUS;

EID: 79960468405     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2011.06.008     Document Type: Article

References (27)

1. Belyakov I.M., Ahlers J.D. What role does the route of immunization play in the generation of protective immunity against mucosal pathogens?. J. Immunol. 2009, 183:6883-6892.
2. Betts M.R., Brenchley J.M., Price D.A., De Rosa S.C., Douek D.C., Roederer M., Koup R.A. Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J. Immunol. Methods 2003, 281:65-78.
3. Bivas-Benita M., Bar L., Gillard G.O., Kaufman D.R., Simmons N.L., Hovav A.H., Letvin N.L. Efficient generation of mucosal and systemic antigen-specific CD8+ T-cell responses following pulmonary DNA immunization. J. Virol. 2010, 84:5764-5774.
4. Brown L.E., Kelso A. Prospects for an influenza vaccine that induces cross-protective cytotoxic T lymphocytes. Immunol. Cell. Biol. 2009, 87:300-308.
5. Carragher D.M., Kaminski D.A., Moquin A., Hartson L., Randall T.D. A novel role for non-neutralizng antibodies against nucleoprotein in facilitating resistance to influenza virus. J. Immunol. 2008, 181:4168-4176.
6. Davis S.S. Nasal vaccines. Adv. Drug Del. Rev. 2001, 51:21-42.
7. Gorton D., Blyth S., Gorton J.G., Govan B., Ketheesan N. An alternative technique for the induction of autoimmune valvulitis in a rat model of rheumatic heart disease. J. Immunol. Methods 2010, 355:80-85.
8. Gotch F., Rothbard J., Howland K., Townsend A., McMichael A. Cytotoxic T lymphocytes recognize a fragment of influenza virus matrix protein in association with HLA-A2. Nature 1987, 326:881-882.
9. Kamala T. Hock immunization: a humane alternative to mouse footpad injections. J. Immunol. Methods 2007, 328:204-214.
10. Kaufman D.R., Bivas-Benita M., Simmons N.L., Miller D., Barouch D.H. Route of adenovirus-based HIV-1 vaccine delivery impacts the phenotype and trafficking of vaccine-elicited CD8+ T lymphocytes. J. Virol. 2010, 84:5986-5996.
11. Kaufman D.R., Liu J., Carville A., Mansfield K.G., Havenga J.E., Goudsmit J., Barouch D.H. Trafficking of antigen-specific CD8+ T lymphocytes to mucosal surfaces following intramuscular vaccination. J. Immunol. 2008, 181:4188-4198.
12. Kerlin R.L., Watson D.L. The secondary immune response to Staphylococcus aureus vaccines in efferent popliteal lymph of sheep. Immunology 1987, 60:295-301.
13. Kohlmeier J.E., Woodland D.L. Immunity to respiratory viruses. Ann. Rev. Immunol. 2009, 27:61-82.
14. Kohyama S., Ohno S., Suda T., Taneichi M., Yokoyama S., Mori M., Kobayashi A., Hayashi H., Uchida T., Matsui M. Efficient induction of cytotoxic T lymphocytes specific for severe acute respiratory syndrome (SARS)-associated coronavirus by immunization with surface-linked liposomal peptides derived from a non-structural polyprotein 1a. Antiviral Res. 2009, 84:168-177.
15. Lin K., Somanathan S., Roy S., Calcedo R., Wilson J.M. Lung homing CTLs and their proliferation ability are important correlates of vaccine protection against influenza. Vaccine 2010, 28:5669-5675.
16. Matsui M., Kohyama S., Suda T., Yokoyama S., Mori M., Kobayashi A., Taneichi M., Uchida T. A CTL-based liposomal vaccine capable of inducing protection against heterosubtypic influenza viruses in HLA-A*0201 transgenic mice. Biochem. Biophys. Res. Commun. 2010, 391:1494-1499.
17. Matsui M., Moriya O., Belladonna M.L., Kamiya S., Lemonnier F.A., Yoshimoto T., Akatsuka T. Adjuvant activities of novel cytokines, interleukine-23 (IL-23) and IL-27 for induction of hepatitis C virus-specific cytotoxic T lymphocytes in HLA-A*0201 transgenic mice. J. Virol. 2004, 78:9093-9104.
18. Matsui M., Moriya O., Yoshimoto T., Akatsuka T. T-bet is required for protection against vaccinia virus infection. J. Virol. 2005, 79:12798-12806.
19. Mora J.R., von Andrian U.H. T-cell homing specificity and plasticity: new concepts and future challenges. Trends Immunol. 2006, 27:235-243.
20. Ohno S., Kohyama S., Taneichi M., Moriya O., Hayashi H., Oda H., Mori M., Kobayashi A., Akatsuka T., Uchida T., Matsui M. Synthetic peptides coupled to the surface of liposomes effectively induce SARS coronavirus-specific cytotoxic T lymphocytes and viral clearance in HLA-A*0201 transgenic mice. Vaccine 2009, 27:3912-3920.
21. Pascolo S., Bervas N., Ure J.M., Smith A.G., Lemonnier F.A., Pérarnau B. HLA-A2.1-restricted education and cytolytic activity of CD8+ T lymphocytes from β2 microglobulin (β2m) HLA-A2.1 monochain transgenic H-2Db β2m double knockout mice. J. Exp. Med 1997, 185:2043-2051.
22. Santosuosso M., Zhang X., McCormick S., Wang J., Hitt M., Xing Z. Mechanisms of mucosal and parenteral tuberculosis vaccinations: adenoviral-based mucosal immunization preferentially elicits sustained accumulation of immune protective CD4 and CD8 T cells within the airway lumen. J. Immunol. 2005, 174:7986-7994.
23. Takashima A., Morita A. Dendritic cells in genetic immunization. J. Leukoc. Biol. 1999, 66:350-356.
24. Vitiello A., Yuan L., Chesnut R.W., Sidney J., Southwood S., Farness P., Jackson M.R., Peterson P.A., Sette A. Immunodominance analysis of CTL responses to influenza PR8 virus reveals two new dominant and subdominant Kb-restricted epitopes. J. Immunol. 1996, 157:5555-5562.
25. Wang J., Thorson L., Stokes R.W., Santosuosso M., Huygen K., Zganiacz A., Hitt M., Xing Z. Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis. J. Immunol. 2004, 173:6357-6365.
26. Wei C.J., Boyington J.C., McTamney P.M., Kong W.P., Pearce M.B., Xu L., Andersen H., Rao S., Tumpey T.M., Yang Z.Y., Nabel G.J. Induction of broadly neutralizing H1N1 influenza antibodies by vaccination. Science 2010, 329:1060-1064.
27. Woodland D., Kohlmeier J.E. Migration, maintenance and recall of memory T cells in peripheral tissues. Nat. Rev. Immunol. 2009, 9:153-161.